Zentalis Pharmaceuticals (ZNTL) Fireside Chat Hints at ZN-c5 Possibly the Best in Class Oral SERD - SVB Leerink
Tweet Send to a Friend
SVB Leerink analyst Andrew Berens reiterated an Outperform rating on Zentalis Pharmaceuticals (NASDAQ: ZNTL) after hosting a virtual fireside chat ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
